1. Academic Validation
  2. TRPC6 effects on albumin permeation, nephrin shedding, and apoptosis in podocytes: Role of calcineurin and metalloproteases

TRPC6 effects on albumin permeation, nephrin shedding, and apoptosis in podocytes: Role of calcineurin and metalloproteases

  • Physiol Rep. 2025 Nov;13(21):e70614. doi: 10.14814/phy2.70614.
Eun Young Kim 1 Stuart E Dryer 1 2
Affiliations

Affiliations

  • 1 Department of Biology and Biochemistry, University of Houston, Houston, Texas, USA.
  • 2 Department of Biomedical Sciences, Tilman J. Fertitta Family College of Medicine, University of Houston, Houston, Texas, USA.
Abstract

The effects of TRPC6 activation for various periods of time on three classes of functional outputs were examined in cultured podocytes: albumin permeation across a confluent layer; changes in nephrin dynamics; and cell death. Albumin permeation in transwell assays was significantly increased within 1 h in response to the activation of formyl peptide receptors (FPR), but the TRPC6 inhibitor SAR-7334 had no effect on this response, and 1 h or 24 h exposures to the TRPC6 activator PPZ2 did not increase albumin permeation. Direct TRPC6 activation for 24 h evoked an increase in shedding of nephrin ectodomains into the surrounding media, accompanied by an increase in matrix metalloprotease-7 (MMP-7). These effects were blocked by the Calcineurin Inhibitor cyclosporin A (CsA), as well as by Batimastat, a broad-spectrum inhibitor of metalloproteinases including MMP-7. TRPC6 activation for 24 h also evoked an increase in occludin abundance but had no effect on the abundance of podocin. Finally, TRPC6 activation for 72 h, but not for 24 h, evoked an increase in apoptotic cell death based on increases in cleaved Caspase-3. This effect was blocked by both SAR-7334 and CsA. TRPC6 activation did not induce Pyroptosis based on the measurement of cleaved gasdermin D.

Keywords

apoptosis; cation channel; effacement; nephrin shedding; podocyte.

Figures
Products
  • Cat. No.
    Product Name
    Description
    Target
    Research Area
  • HY-13564
    98.92%, MMP Inhibitor
    MMP